Lung Cancer
A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 versus Standard of Care in Subjects with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
- Details
ClinicalTrials.gov ID:
NCT07365241
Diagnosis Type:
NA
USOR Number:
- Address
,
P: